Charmacy Pharmaceutical Co., Ltd. — Capital/Financing Update 2017

Dec 14, 2017

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [66 x 55] intentionally omitted <==

CHARMACY PHARMACEUTICAL CO., LTD. 創美藥業股份有限公司

(A joint stock limited liability company incorporated in the People’s Republic of China)

(Stock Code: 2289)

INSIDE INFORMATION

ACCEPTANCE BY CHINA SECURITIES REGULATORY COMMISSION OF APPLICATION MATERIALS FOR THE PROPOSED A SHARE OFFERING

This announcement is made by Charmacy Pharmaceutical Co., Ltd. (the “ Company ”) pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”) and the inside information provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Reference is made to the announcement of the Company dated 20 July 2017, the circular of the Company dated 15 August 2017, and the poll results announcement of the general meeting of the Company dated 5 September 2017 respectively, which include, among other things, matters related to the proposed A share offering by the Company (the “ Proposed A Share Offering ”).

The Company is pleased to announce that the Company has submitted application materials in respect of the Proposed A Share Offering, including the A share prospectus (the “ A Share Prospectus ”), to the China Securities Regulatory Commission (the “ CSRC ”), and CSRC has accepted the application. The A Share Prospectus will be published on the website of CSRC at www.csrc.gov.cn in due course and pursuant to Rule 13.10B of the Listing Rules, the website of Hong Kong Exchanges and Clearing Limited at www.hkexnews.hk and the website of the Company at www.chmyy.com simultaneously.

As the Proposed A Share Offering is subject to the approval by the CSRC ， it may or may not completed. Shareholders and potential investors of the Company should exercise caution when dealing in the H shares of the Company. Further announcements will be made by the Company as and when appropriate in respect of any material developments relating to the Proposed A Share Offering. This announcement appears for information purposes only and

– 1 –

does not constitute an invitation or an offer to acquire, purchase or subscribe for the securities of the Company.

By order of the Board Charmacy Pharmaceutical Co., Ltd. Yao Chuanglong Chairman

Shantou, the PRC, 14 December 2017

As at the date of this announcement, the executive Directors are Mr. Yao Chuanglong, Ms. Zheng Yuyan and Mr. Lin Zhixiong; the non-executive Director is Mr. Li Weisheng; and the independent non-executive Directors are Mr. Wan Chi Wai Anthony, Mr. Zhou Tao and Mr. Guan Jian (also known as Guan Suzhe).

– 2 –